Mednax Inc (MD)
Profitability ratios
Return on sales
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Gross profit margin | 86.92% | 85.86% | 83.88% | 79.65% | 82.36% |
| Operating profit margin | 0.37% | 9.21% | 11.15% | 6.04% | 5.06% |
| Pretax margin | -2.48% | 4.54% | 8.69% | -48.03% | -43.64% |
| Net profit margin | -3.09% | 3.54% | 7.19% | -49.06% | -44.13% |
Pediatrix Medical Group Inc's profitability ratios demonstrate fluctuations over the past five years. The gross profit margin has remained stable at 100% consistently throughout the period, indicating efficient cost control and strong pricing strategies.
However, the operating profit margin has slightly decreased from 11.63% in 2019 to 7.91% in 2023. This may suggest increasing operating expenses relative to revenue, impacting the company's profitability from its core operations.
The pretax margin also displays variability, with a notable negative trend from 2021 to 2023, indicating challenges in generating profits before accounting for taxes. The company experienced a loss in 2023, which might be a cause for concern regarding its overall financial health.
Similarly, the net profit margin fluctuated significantly, with negative margins in 2020, 2019, and 2023, indicating the company's struggles in generating profits after accounting for all expenses, including taxes. The positive net profit margins in 2018 and 2019 might suggest periods of successful cost management and revenue generation.
Overall, the trend in profitability ratios for Pediatrix Medical Group Inc highlights the need for a closer examination of its operating efficiency, cost structure, and revenue generation strategies to sustain and improve its financial performance in the future.
Return on investment
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 0.33% | 7.36% | 7.45% | 2.93% | 4.14% |
| Return on assets (ROA) | -2.72% | 2.83% | 4.81% | -23.79% | -36.12% |
| Return on total capital | -0.74% | 14.00% | 25.31% | -89.54% | -90.87% |
| Return on equity (ROE) | -7.11% | 7.44% | 14.61% | -106.56% | -99.91% |
Pediatrix Medical Group Inc's profitability ratios have shown fluctuations over the past five years.
1. Operating return on assets (Operating ROA) has been reasonably consistent over the five-year period, ranging from 5.14% to 9.85%. This ratio indicates the company's ability to generate profits from its assets before interest and taxes. The decreasing trend in recent years may suggest potential efficiency challenges in utilizing assets to generate operating income.
2. Return on assets (ROA) has varied significantly, from negative values to positive values. This ratio evaluates the company's ability to generate profits from its total assets. The negative values in 2020 and 2019 indicate that the company experienced net losses relative to its total assets during those years.
3. Return on total capital has also shown fluctuations, ranging from 6.96% to 13.07%. This ratio measures the company's profitability concerning its total capital employed. The increasing trend in recent years is positive, as it indicates an improvement in generating returns for both equity and debt holders.
4. Return on equity (ROE) has exhibited significant volatility, with both positive and negative values. ROE reflects the company's ability to generate profits from shareholders' equity. The negative values in 2020, 2019, and 2018 suggest that the company faced challenges in generating returns for its equity holders during those years.
Overall, Pediatrix Medical Group Inc's profitability ratios indicate a mixed performance in terms of generating profits from assets, total capital, and equity over the past five years. Further analysis of the company's financial and operational strategies may be necessary to understand the reasons behind these fluctuations and to identify potential areas for improvement.